Dethlefs Sven
SEC CIK 1726010 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, North America Commercial | 165.4K | — | $1.49M | 10 | 2022-02-09 | 2023-03-06 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Dethlefs Sven made no open-market trades at TEVA in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-08 | 2023-03-06+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | S - Sale | $9.55 | -77.4K | 165.4K | -32% | -$739.8K |
| DM | 2023-03-07 | 2023-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | M - OptEx | — | +77.4K | 179.3K | +76% | — |
| DM | 2023-03-02 | 2023-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | S - Sale+OE | $9.89 | -59.7K | 165.4K | -27% | -$590.0K |
| DM | 2023-03-02 | 2023-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | M - OptEx | — | +59.7K | 182.7K | +48% | — |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | S - Sale+OE | $7.41 | -10.9K | 147.4K | -7% | -$80.7K |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | M - OptEx | — | +76.8K | 172.4K | +80% | — |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | S - Sale+OE | $8.14 | -4,862 | 99.5K | -5% | -$39.6K |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | M - OptEx | — | +17.3K | 104.3K | +20% | — |
| D | 2022-02-10 | 2022-02-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | M - OptEx | — | +13.1K | 91.1K | +17% | — |
| D | 2022-02-10 | 2022-02-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dethlefs Sven | EVP, North America Commercial | S - Sale+OE | $9.06 | -4,138 | 87.0K | -5% | -$37.5K |
Purchase Sale Sale after option exercise All abbreviations